Contract Pharmaceutical Manufacturing Services in Softgel Technologies
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Softigel by Procaps

Contract Pharmaceutical Development Services and Commercial Manufacturing in Advanced Softgel Technologies

Softigel by Procaps is a leading supplier of contract development and manufacturing services in softgel advanced technologies for pharmaceutical companies across the world.

Calle 80 # 78B – 201,

contract pharmaceutical manufacturing

Softigel by Procaps is a leading supplier of contract development and manufacturing services in softgel advanced technologies for pharmaceutical companies across the world.

The company assists in helping various businesses bring innovative products to market faster through its extensive capabilities and deep expertise in product development and softgel manufacturing. Softigel by Procaps offers consumers and patients super adherence, exceptional experience, and higher preference to alternative therapies.

To become an integrated contract development and manufacturing organisation (iCDMO), Softigel by Procaps combined its advanced delivery technologies with proven regulatory, formulation and manufacturing expertise. The company provides its clients with full-service, turnkey solutions in prescription medications, over-the-counter (OTC) and dietary supplements across both development and distribution.

Contract development and manufacturing services for the pharmaceutical industry

Softigel by Procaps specialises in challenging-to-manufacture drugs, geared to identifying and developing business opportunities in both generic and highly regulated markets, particularly in niche divisions where there is inadequate competition.

The company’s distinguishing strengths allow it to move into difficult-to-manufacture dosage forms, formulations, compounds and non-traditional production methods.

Working on developing opportunities with resilient long-term partnerships from breakthrough technologies, Softigel by Procaps is infused with a strong belief in the developing need for generic drugs, advanced delivery technologies and speciality pharma products.

Due to the company’s vertical integration and cutting-edge research and development (R&D), Softigel by Procaps is uniquely qualified to meet the market’s requirements.

The company works alongside both small and large pharmaceutical businesses seeking integrated, strategic partners offering advanced technologies and expertise, driving demand for integrated services from proof-of-concept to commercialisation.

Drug delivery technologies

Softigel by Procaps provides an extensive portfolio, with a vast array of products ranging from a single unit dosage form to multiple delivery systems in one dose. The company’s softgel-related technologies include:

  • Twist-off capsules
  • Chewgels™, chewable soft capsules
  • G-Tabs™, gelatine-coated tablets
  • Versagels™, soft chewable capsules free from animal derivatives
  • Unigel™, a novel technology for fixed-dose combinations

Other technologies offered by the company comprise:

  • Hard gel capsules
  • Gels
  • Ointments
  • Creams
  • Prefilled syringes
  • Powders
  • Tablets
  • Omega-3 high concentrates
  • Gummygels™, nutraceutical gummies

Product development services

Softigel by Procaps’ pioneering softgel facilities comprises a fully integrated product development services (PDS) unit, which, in the same plant, covers a vast array of product lifecycle phases from early development to commercialisation.

The company’s contemporary facility employs equipment replication from lab-scale through to small-scale good manufacturing practice (GMP) batches, as well as full-scale commercial GMP.

Its R&D team provides clients with access to encapsulation in softgel dosage forms or other delivery systems, differentiated OTC products and nutritional supplements, formulation of simple or highly complex products, high or low potent active pharmaceutical ingredients (APIs), traditional and unique delivery systems, and value and support throughout all stages.

Softigel by Procaps has proven expertise in manufacturing technologies, product development, product launches and technology transfers, enabling its clients to surmount formulation challenges.

The specialised team works intimately alongside its clients to better understand expectations and develop a regulatory strategy that ensures optimum quality, timely submissions, and quicker, more positive registration results.

The company also has extensive knowledge in preparing submissions in electronic clinical trial document (eCTD) format, offering support during the application phase, including annual reports, as well as other post-approval applications.

R&D services for advanced pharmaceutical formulations

A primary factor in the company’s market success is its R&D department, a team continually working on the expansion of advanced formulas, as well as new pharmaceutical technologies.

Softigel by Procaps annually develops more than 50 new veterinary, cosmetics, nutritional and pharmaceutical products, based on industry trends across the world.

Quality certifications

Softigel by Procaps holds quality certifications from numerous entities, including:

  • Organic Certified gummies facility
  • Cofepris in Mexico
  • HALAL-certified gelatine
  • Colombian Agriculture Institute (ICA)
  • Ministry of Health (MOH) in Iran
  • The US Food and Drug Administration (FDA)
  • FDA Philippines
  • Brazilian Health Regulatory Agency (ANVISA)
  • The National Administration of Medicines, Food and Medical Technology (ANMAT) of Argentina
  • GMP
  • International Standardisation of Organisation (ISO) 9001
  • Health Canada
  • Therapeutic Goods Administration (TGA) in Australia
  • EU GMP from the Medicines and Healthcare Products Regulatory Agency (MHRA)

Chewgels – Chewable Softgels

Softigel’s chewable capsules come in different shapes and flavours and are great for pets, children or adults who are unable to take regular hard-capsule forms.

G-Tabs™ – Gelatin Coated Tablets

G-tabs™ is a technology for the coating of tablets with either a one or a two-toned colour gelatin. They can also be printed or not printed.


Softigel is dedicated to the manufacture, research and development of omega-3 extracts from fish oil.

Other Drug Delivery Forms

Softigel’s products use a variety of delivery methods, including tablets, powders, syrups, suspensions, creams, drops and emulsions.

Other Services

Softigel’s seven cutting-edge facilities house a fully integrated product development services (PDS) unit, which covers a wide range of product lifecycle phases from early development to commercialisation in the same plant, using equipment replication from lab scale, through small-scale good manufacturing practice (GMP) batches, until full-scale commercial GMP.

Procaps Plants

Procaps is a multinational company with more than 35 years of expertise in manufacturing softgels and advanced new drug delivery techniques.

The Softigel Experience

Softigel is a pharmaceutical group dedicated to delivering innovation, health and nutrition.

What’s Behind Vegetarian Soft Capsules

The present is an overview of the state-of-the-art for vegetarian soft capsules in terms of materials (sourcing and demand), applications, processing, products and a general insight of the current state of materials and technology of these gelatin alternatives.

Advantages of Soft Gelatin Capsules Dosing Form

Cannabis-based products are manufactured, mainly, from oils obtained from a synthetic way as Dronabinol or obtained from plants of genus Cannabis, as Cannabidiol (CBD) oils.

Softigel by Procaps Announces New Website Launch

Softigel by Procaps, a leading provider of contract development and manufacturing services in softgel advanced technologies for the pharmaceutical and nutraceutical industries, is proud to announce the launch of its newly revamped website.

Join Softigel at CPhI

Softigel by Procaps will be attending CPhi North America´s second edition once again.

Meet Softigel by Procaps at CPhI

Softigel by Procaps will be attending CPhI Worldwide in Paris from 7-9 October, where our team of experts will be available to discuss mutual opportunities.


Av. Patriotismo N° 229 Piso 7Ofic. N° 206

Col. San Pedro De Los Pinos

Deg. Benito Juarez

Mexico D.F.



Maipú 1210 Piso 8, oficina 817, C1006

Buenos Aires



Estrada dos Estudantes, 349



Sao Paulo



Sofgen Pharmaceuticals

1815 Griffin Road, Suite 404

Dania Beach

FL 33004

United States of America